Pre-Clinical (Discovery and Development)
Find out how to fill up your pipeline and increase innovation. Pharma IQ is proud to provide an international, non-biased, central resource, for professionals working in early discovery and preclinical research to exchange ideas on best practice and share case studies on innovation within the area.
Top 10 Clinical Research Organisations in the Pharma & Biotech Industry - 2016
March 15 by Chanice HenryIn light of this growing market, in 2016 the Pharma IQ community was invited to rate which firms would appear in their list of top 10 CROs.
Industry Forecast: 2017 Trends
January 13 by Dr Steven BradshawAt the end of last year, Dr Steven Bradshaw examined whether 2016's pharmaceutical predictions came to fruition. Now, he sets his forecasts for the oncoming year.
Top Content For 2015
December 22 by Chanice HenryPharma IQ presents the top content pieces for 2015 in this annual bumper, so you can browse through some of this year’s best articles to feature on the portal.Contents1. Top 10 Clinical Research...
Biobanking Research Report
December 22 by Pharmaceuticals & Biotechnology EditorPharma IQ presents its Biobanking Trend Research Report Survey for 2016. Please participate via the box below. Have Your Say Rate this feature and give us your feedback in the comments section...
Specialists Gather for CRISPR Gene Editing Summit
December 15 by Chanice HenryLast week a select collection of CRISPR Cas9 enthusiasts gathered to debate both the bright future and the flaring issues facing the technique, which has trailblazed its way through the market.The eve...
Imposter Syndrome And The Box Of Delights That Is Science
November 24 by Chanice HenryAs discussions circled around the concept of women in science feeling ‘imposter syndrome’ in what many perceive as a male dominated industry, at this month’s Biobeat 15, Professor...
The R&D Race behind Immune Checkpoint Modulators
November 14 by Chanice HenryThe cancer immunotherapy market is primed for growth, with Immune Checkpoint Inhibitors, otherwise known as Immune Checkpoint Modulators, representing one of the area’s newest and most promising treat...
Data Challenges in Biologics Development
November 05 by Pharmaceuticals & Biotechnology EditorThis paper explores how a single, enterprise data-management platform can improve biologics development lifecycles. The paper examines the challenges faced by biopharmaceutical professionals in thei...
CRISPR Cas9 Troubleshooting Analysis
October 12 by Pharmaceuticals & Biotechnology EditorThe CRISPR Cas9 tool has attracted worldwide attention from the R&D industry in regards to its capabilities for gene editing. The cutting edge method is being used to revolutionize re...
Maximising ROI Within Clinical Trial Supply
October 12 by Pharmaceuticals & Biotechnology EditorWith the help of industry experts, this Pharma IQ infographic highlights key methods to maximise returns within clinical trial supply. Download the infographic below. [in...
It’s All About “Me”: Making and Assaying Active Histone Methyltransferases
October 06 by Pharma IQPlease note that this webinar is now available on demand. Login to view. Histone Methyltransferases (HMTs) are emerging as new targets for drug discovery at a time when our knowledge of how these...